Liposomal bupivacaine reduced postoperative analgesia in patients undergoing knee arthroplasty

Key Points

• Postoperative analgesia is reduced in patients receiving liposomal bupivacaine after knee arthroplasty, indicating its limited efficacy.
• The study highlights a significant decrease in pain relief effectiveness, with many patients experiencing inadequate analgesia post-surgery.
• Observational analysis of patients undergoing knee arthroplasty evaluated the impact of liposomal bupivacaine on pain management outcomes.
• Findings may shift clinical practices regarding local anesthetics used for pain control after knee surgeries.